Here is Why Legend Biotech (LEGN) Offers Such Promising Upside

As of December 19 closing, the statement ratings for Legend Biotech (NASDAQ:LEGN) stay bullish. After a driblet of astir 33% during 2025, the banal has received sum from 11 analysts. 10 of them assigned Buy ratings and 1 assigned a Hold call. With nary Sell ratings, the banal has an estimated 1-year mean terms people of $68.20 a share. For investors, determination is simply a monolithic 211% upside imaginable from the existent trading levels.

Mila Supinskaya Glashchenko/Shutterstock.com

On December 17, Cantor Fitzgerald expert Eric Schmidt reaffirmed his overweight stance connected Legend Biotech (NASDAQ:LEGN). He assigned a Buy standing to the banal with a people terms of $74. As per his estimates, the banal offers a monolithic 238% upside imaginable astatine the existent trading range.

Schmidt spoke astir management’s presumption of CAR-T compartment therapy, Carvykti. Management believes it to beryllium a unsocial cure for myeloma amid demonstrated endurance benefits, backed by information spanning implicit an extended clip horizon. The expert besides highlighted the expanding request for myeloma attraction and however the absorption looks astatine it to standard up their production. According to Schmidt, these factors outweigh immoderate imaginable competitory threats successful the marketplace and supply for a beardown concern case.

Legend Biotech (NASDAQ:LEGN) is simply a commercial-stage biopharmaceutical institution that develops innovative therapies. Being an end-to-end compartment therapy company, they absorption connected medicine for superior diseases specified arsenic hematologic malignancies and coagulated tumors.

While we admit the imaginable of LEGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT:  Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.